Affinity Life Sciences

Affinity Life Sciences

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Affinity Life Sciences is a private, revenue-generating contract manufacturer serving the in vitro diagnostics (IVD), medical device, and biopharma sectors. Its core capabilities include specialized lyophilization (freeze-drying) of assay components, full reagent and kit manufacturing, and immunoassay/companion diagnostic development. The company leverages its regulatory-compliant infrastructure and technical expertise to act as a single-source partner for clients, aiming to reduce costs and accelerate time-to-market for critical diagnostic and therapeutic products.

DiagnosticsMedical Devices

Technology Platform

Integrated CDMO services platform specializing in lyophilization (freeze-drying), reagent/kit manufacturing, immunoassay development, cell culture, and protein chemistry under cGMP/ISO 13485 compliance.

Opportunities

Growth is driven by increasing outsourcing in the diagnostics sector, particularly for lyophilized reagents needed in point-of-care and stable diagnostic tests.
Partnerships with established reagent companies like HyTest provide long-term, exclusive manufacturing contracts and validate its technical capabilities.

Risk Factors

Revenue is dependent on a limited number of client contracts, creating concentration risk.
The company faces significant regulatory risk as a cGMP manufacturer, where any quality failure could damage its reputation and certifications.
It operates in a highly competitive CDMO landscape with pricing pressure.

Competitive Landscape

Affinity competes within the niche of diagnostic-focused CDMOs, against larger global players (e.g., Lonza, Thermo Fisher) and smaller specialized firms. Its key differentiator is its deep expertise in lyophilization for IVD components and its integrated, single-source service model for diagnostic assay manufacturing.